In contrast, in pancreatic ductal adenocarcinoma, silencing FBXO11 suppresses tumor development [44], which may involve the ubiquitination of p53, supporting an oncogenic role in this cancer type. The gene discussed is TP53; the disease is pancreatic ductal adenocarcinoma.